Status:
TERMINATED
Bowel Preparation for Colonoscopy in Children
Lead Sponsor:
Children's Hospital of Philadelphia
Conditions:
Colonoscopy Preparation
Eligibility:
All Genders
6-21 years
Phase:
PHASE4
Brief Summary
The primary objective of this study is to determine whether Miralax results in a more efficacious preparation as compared to senna for pediatric colonoscopy.
Detailed Description
Study subjects will be randomized in two groups: Group one will receive 1.5 g/kg of Miralax orally the day before procedure and one day of clear liquid diet, while subjects in Group 2 will receive two...
Eligibility Criteria
Inclusion
- Subjects age 6-21 yrs for senna, PEG-P groups
- Subjects age 13-21 yrs for NaP group
- First time colonoscopy
- Patient weight \<70 kg for PEG-P group (to not exceed 51 grams/dose)
Exclusion
- Chronic renal, liver, or heart failure
- Chronic constipation
- Patients on the GI inpatient or consult service.
- Subjects taking senna or PEG on a regular basis for laxative reasons.
- Pregnant or lactating females
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT01140295
Start Date
September 1 2010
End Date
May 1 2011
Last Update
April 12 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States, 19104